BHI Therapeutic Sciences   Report issue

For profit Phase 1
Founded: Hackensack NJ United States (2017)

Organization Overview

First Clinical Trial
2019
NCT03735277
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

BHI Therapeutic Sciences